Rescuing qkv dysmyelination by a single isoform of the selective RNA-binding protein QKI

Journal of Neuroscience

Volumn 26, Issue 44, 2006, Pages 11278-11286

  Zhao, Lixia ^a   Tian, Donghua ^a   Xia, Mingjing ^a   Macklin, Wendy B ^b   Feng, Yue ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

MBP; Myelin basic protein; Myelination; PLP; Proteolipid protein; qkv; QKI RNA binding protein; Quakingviable

Indexed keywords

ISOPROTEIN; MESSENGER RNA; MUTANT PROTEIN; MYELIN BASIC PROTEIN; PROTEIN QKI 6; PROTEOLIPID PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; MYELIN PROTEIN; QK PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINEAGE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS CALLOSUM; ELECTRON MICROSCOPY; GENE EXPRESSION; IMMUNOBLOTTING; MOUSE; MYELIN DEFICIENCY; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DEMYELINATING DISEASE; FEMALE; GENETICS; METABOLISM; MOUSE MUTANT; MYELIN SHEATH;

ANIMALS; DEMYELINATING DISEASES; FEMALE; MICE; MICE, QUAKING; MICE, TRANSGENIC; MYELIN PROTEINS; MYELIN SHEATH; PROTEIN BINDING; PROTEIN ISOFORMS; RNA-BINDING PROTEINS;

EID: 33750938519     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2677-06.2006     Document Type: Article

References (42)

1. Aberg K, Saetre P, Jareborg N, Jazin E (2006) Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc Natl Acad Sci USA 103:7482-7487.
2. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ, Stiles CD (2004) bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306:2111-2115.
3. Burton A (2005) Olig1 needed for remyelination. Lancet Neurol 4:80.
4. Campagnoni AT, Macklin WB (1988) Cellular and molecular aspects of myelin protein gene expression. Mol Neurobiol 2:41-89.
5. Campagnoni AT, Sorg B, Roth HJ, Kronquist K, Newman SL, Kitamura K, Campagnoni C, Crandall B (1987) Expression of myelin protein genes in the developing brain. J Physiol (Paris) 82:229-238.
6. Casaccia-Bonnefil P, Hardy RJ, Teng KK, Levine JM, Koff A, Chao MV (1999) Loss of p27Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation. Development 126:4027-4037.
7. Cox RD, Hugill A, Shedlovsky A, Noveroske JK, Best S, Justice MJ, Lehrach H, Dove WF (1999) Contrasting effects of ENU induced embryonic lethal mutations of the quaking gene. Genomics 57:333-341.
8. Dapper JD, Justice MJ (2005) Defining the breakpoints of the quaking(viable) mouse mutation reveals a duplication from a Parkin intron. Mov Disord 20:1369-1374.
9. Durand B, Gao FB, Raff M (1997) Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J 16:306-317.
10. Ebersole T, Rho O, Artzt K (1992) The proximal end of mouse chromosome 17: new molecular markers identify a deletion associated with quakingviable. Genetics 131:183-190.
11. Ebersole TA, Chen Q, Justice MJ, Artzt K (1996) The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins. Nat Genet 12:260-265.
12. Fuss B, Mallon B, Phan T, Ohlemeyer C, Kirchhoff F, Nishiyama A, Macklin WB (2000) Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein. Dev Biol 218:259-274.
13. Galarneau A, Richard S (2005) Target RNA motif and target mRNAs of the Quaking STAR protein. Nat Struct Mol Biol 12:691-698.
14. Hardy RJ (1998) Molecular defects in the dysmyelinating mutant quaking. J Neurosci Res 51:417-422.
15. Hardy RJ, Loushin CL, Friedrich Jr VL, Chen Q, Ebersole TA, Lazzarini RA, Artzt K (1996) Neural cell type-specific expression of QKI proteins is altered in quakingviable mutant mice. J Neurosci 16:7941-7949.
16. Hogan EL, Greenfield S (1984) Animal model of genetic disorders of myelin. New York: Plenum.
17. Jacque C, Delassalle A, Raoul M, Baumann N (1983) Myelin basic protein deposition in the optic and sciatic nerves of dysmyelinating mutants quaking, jimpy, Trembler, mld, and shiverer during development. J Neurochem 41:1335-1340.
18. Kondo T, Furuta T, Mitsunaga K, Ebersole TA, Shichiri M, Wu J, Artzt K, Yamamura K, Abe K (1999) Genomic organization and expression analysis of the mouse qkI locus. Mamm Genome 10:662-669.
19. Larocque D, Pilotte J, Chen T, Cloutier F, Massie B, Pedraza L, Couture R, Lasko P, Almazan G, Richard S (2002) Nuclear retention of MBP mRNAs in the quaking viable mice. Neuron 36:815-829.
20. Larocque D, Galarneau A, Liu HN, Scott M, Almazan G, Richard S (2005) Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation. Nat Neurosci 8:27-33.
21. Li Z, Zhang Y, Li D, Feng Y (2000) Destabilization and mislocalization of myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNA-binding proteins. J Neurosci 20:4944-4953.
22. Lockhart PJ, O'Farrell CA, Farrer MJ (2004) It's a double knock-out! The quaking mouse is a spontaneous deletion of parkin and parkin coregulated gene (PACRG). Mov Disord 19:101-104.
23. Lorenzetti D, Antalffy B, Vogel H, Noveroske J, Armstrong D, Justice M (2004a) The neurological mutant quaking(viable) is Parkin deficient. Mamm Genome 15:210-217.
24. Lorenzetti D, Bishop CE, Justice MJ (2004b) Deletion of the Parkin coregulated gene causes male sterility in the quaking(viable) mouse mutant. Proc Natl Acad Sci USA 101:8402-8407.
25. Lu Z, Zhang Y, Ku L, Wang H, Ahmadian A, Feng Y (2003) The quakingviable mutation affects qkI mRNA expression specifically in myelin-producing cells of the nervous system. Nucleic Acids Res 31:4616-4624.
26. Mallon BS, Shick HE, Kidd GJ, Macklin WB (2002) Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci 22:876-885.
27. McInnes LA, Lauriat TL (2006) RNA metabolism and dysmyelination in schizophrenia. Neurosci Biobehav Rev 30:551-561.
28. Pilotte J, Larocque D, Richard S (2001) Nuclear translocation controlled by alternatively spliced isoforms inactivates the QUAKING apoptotic inducer. Genes Dev 15:845-858.
29. Privat A, Jacque C, Bourre JM, Dupouey P, Baumann N (1979) Absence of the major dense line in myelin of the mutant mouse "shiverer." Neurosci Lett 12:107-112.
30. Readhead C, Popko B, Takahashi N, Shine HD, Saavedra RA, Sidman RL, Hood L (1987) Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype. Cell 48:703-712.
31. Roth HJ, Hunkeler MJ, Campagnoni AT (1985) Expression of myelin basic protein genes in several dysmyelinating mouse mutants during early postnatal brain development. J Neurochem 45:572-580.
32. Sidman RL, Dickie MM, Appel SH (1964) Mutant mice (Quaking and Jimpy) with deficient myelination in the central nervous system. Science 144:309-311.
33. Singh H, Spritz N, Geyer B (1971) Studies of brain myelin in the "quaking mouse." J Lipid Res 12:473-481.
34. Sorg BA, Smith MM, Campagnoni AT (1987) Developmental expression of the myelin proteolipid protein and basic protein mRNAs in normal and dysmyelinating mutant mice. J Neurochem 49:1146-1154.
35. Sorg BJ, Agrawal D, Agrawal HC, Campagnoni AT (1986) Expression of myelin proteolipid protein and basic protein in normal and dysmyelinating mutant mice. J Neurochem 46:379-387.
36. Vernet C, Artzt K (1997) STAR, a gene family involved in signal transduction and activation of RNA. Trends Genet 13:479-484.
37. Vouyiouklis DA, Brophy PJ (1993) Microtubule-associated protein MAP1B expression precedes the morphological differentiation of oligodendrocytes. J Neurosci Res 35:257-267.
38. Wu J, Zhou L, Tonissen K, Tee R, Artzt K (1999) The quaking I-5 protein (QKI-5) has a novel nuclear localization signal and shuttles between the nucleus and the cytoplasm. J Biol Chem 274:29202-29210.
39. Xin M, Yue T, Ma Z, Wu FF, Gow A, Lu QR (2005) Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J Neurosci 25:1354-1365.
40. Zhang Y, Feng Y (2001) Distinct molecular mechanisms lead to diminished myelin basic protein and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in qk(v) dysmyelination. J Neurochem 77:165-172.
41. Zhang Y, Lu Z, Ku L, Chen Y, Wang H, Feng Y (2003) Tyrosine phosphorylation of QKI mediates developmental signals to regulate mRNA metabolism. EMBO J 22:1801-1810.
42. Zhao L, Ku L, Chen Y, Xia M, Lopresti P, Feng Y (2006) QKI binds MAP1B mRNA and enhances MAP1B expression during oligodendrocyte development. Mol Biol Cell 17:4179-4186.